- Home
- PAGS vs KNSA Comparison
PAGS vs KNSA Comparison
Compare PAGS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAGS
- KNSA
- Stock Information
- Founded
- PAGS 2006
- KNSA 2015
- Country
- PAGS Brazil
- KNSA United Kingdom
- Employees
- PAGS N/A
- KNSA N/A
- Industry
- PAGS EDP Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- PAGS Technology
- KNSA Health Care
- Exchange
- PAGS Nasdaq
- KNSA Nasdaq
- Market Cap
- PAGS 2.3B
- KNSA 1.9B
- IPO Year
- PAGS N/A
- KNSA 2018
- Fundamental
- Price
- PAGS $9.02
- KNSA $33.38
- Analyst Decision
- PAGS Buy
- KNSA Strong Buy
- Analyst Count
- PAGS 7
- KNSA 6
- Target Price
- PAGS $11.36
- KNSA $40.83
- AVG Volume (30 Days)
- PAGS 4.7M
- KNSA 707.4K
- Earning Date
- PAGS 08-13-2025
- KNSA 07-29-2025
- Dividend Yield
- PAGS 1.55%
- KNSA N/A
- EPS Growth
- PAGS 20.55
- KNSA N/A
- EPS
- PAGS 1.30
- KNSA 0.07
- Revenue
- PAGS $3,543,799,551.00
- KNSA $529,332,000.00
- Revenue This Year
- PAGS $19.47
- KNSA $37.21
- Revenue Next Year
- PAGS $6.37
- KNSA $6.10
- P/E Ratio
- PAGS $6.96
- KNSA $516.43
- Revenue Growth
- PAGS 14.53
- KNSA 56.18
- 52 Week Low
- PAGS $6.11
- KNSA $17.82
- 52 Week High
- PAGS $14.82
- KNSA $33.98
- Technical
- Relative Strength Index (RSI)
- PAGS 57.68
- KNSA 66.14
- Support Level
- PAGS $8.52
- KNSA $31.78
- Resistance Level
- PAGS $9.45
- KNSA $33.66
- Average True Range (ATR)
- PAGS 0.28
- KNSA 1.26
- MACD
- PAGS 0.15
- KNSA 0.19
- Stochastic Oscillator
- PAGS 74.93
- KNSA 87.34
About PAGS PagSeguro Digital Ltd.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.